Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LOUISVILLE, CO--(Marketwired - November 17, 2015) - AntriaBio, Inc. ("AntriaBio" or the "Company") (OTCQB: ANTB), a biopharmaceutical corporation developing novel extended release therapies,...
-
LOUISVILLE, CO--(Marketwired - September 16, 2015) - AntriaBio, Inc. ("AntriaBio" or the "Company") (OTCQB: ANTB), a biopharmaceutical corporation developing novel extended release therapies,...
-
LOUISVILLE, CO--(Marketwired - June 29, 2015) - AntriaBio, Inc. ("AntriaBio" or the "Company") (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies,...
-
LOUISVILLE, CO--(Marketwired - June 08, 2015) - AB101 drug substance retained similar receptor binding affinity and receptor-mediated biological activity compared to native insulinSingle dose...
-
LOUISVILLE, CO--(Marketwired - May 11, 2015) - AntriaBio, Inc. ("AntriaBio" or the "Company") (OTCQB: ANTB), a biopharmaceutical corporation developing novel extended release therapies, announced...
-
LOUISVILLE, CO and MENLO PARK, CA--(Marketwired - Jan 8, 2015) - AntriaBio, Inc. ("AntriaBio or the "Company") (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended...
-
LOUISVILLE, CO--(Marketwired - Jan 7, 2015) - AntriaBio, Inc. ("AntriaBio or the "Company") (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies,...
-
LOUISVILLE, CO--(Marketwired - Jan 5, 2015) - AntriaBio, Inc. ("Company") (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies, announced today that...
-
LOUISVILLE, CO--(Marketwired - Nov 10, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies, announced today that it has...
-
MENLO PARK, CA--(Marketwired - Jun 23, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel therapeutics to treat patients with diabetes and metabolic...